J. Alexandre

Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy

J. Alexandre, M. Gross-Goupil, Bruno Falissard et al. · Annals of Oncology · 2002 · 130 citations

Inflammatory Status, Oncology, Cancer Management +10

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO)

Alain Lortholary, R. Largillier, B. Weber et al. · Annals of Oncology · 2011 · 92 citations · Full text

Resistant Ovarian Cancer, Oncology, Weekly Topotecan +9

Relationship between GSTP1 Ile105Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity

Olivier Mir, J. Alexandre, A. Tran et al. · Annals of Oncology · 2009 · 84 citations

Docetaxel-induced Peripheral Neuropathy, Gstp1 Ile105val Polymorphism, Medicine +7

Stage I non-seminomatous germ-cell tumours of the testis

J. Alexandre, Karim Fizazi, C Mahé et al. · European Journal of Cancer · 2001 · 75 citations

Tumoral Pathology, Germ Cell, Medicine +7

Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study

J. Alexandre, Elisabeth Rey, V. Girre et al. · Annals of Oncology · 2006 · 64 citations · Full text

Inflammation, Inflammatory Status, Anti-inflammatory +8